Vancouver, B.C., December 21, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (OTC:MYMMF) (the “Company” or “MYM”) is pleased to announce that applications for a medicinal cannabis license for the Northern Rivers Project in Australia, for both cultivation and production, can-nabis research license and manufacturing license have been accepted by the Office of Drug Control (ODC). The applications have now progressed to the assessment phase, all associated fees have been paid. The company will continue to provide updates as appropriate while it progresses through the process. The company would like to announce that the it will begin operating under a new corporate name and will be known as Solaris Nutraceuticals Pty Ltd. (formerly " PUF Ventures Aus-tralia"). Michael Horsfall, President and CEO, said "The new name reflects our focus on distinct inno-vations to provide medicinal cannabis grown under the Northern Rivers Sun in our proposed 1.2 Million square foot Ultra-Clima glasshouse. In addition to our name change, you will see a fresh new look and feel to the corporate image of the company which reflects the innova-tion, quality and environmentally sustainable products to be developed in our glasshouse and manufacturing facilities. MYM Nutraceuticals (CSE: MYM) and PUF Ventures Inc. (CSE: PUF) are co-owners in Solaris Nutraceuticals.
|
